# ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir

> **NCT02609399** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 180 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Oseltamivir
- **DRUG:** Peramivir

## Key facts

- **NCT ID:** NCT02609399
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-01
- **Primary completion:** 2017-05-26
- **Final completion:** 2018-05-31
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2019-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02609399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02609399, "ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02609399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*